Inactive Instrument

Primary Health Care Limited Stock Australian S.E.

Equities

AU000000PRY5

Healthcare Facilities & Services

Sales 2024 * 1.72B 1.12B Sales 2025 * 1.8B 1.17B Capitalization 908M 592M
Net income 2024 * -632M -412M Net income 2025 * 26M 16.95M EV / Sales 2024 * 1.4 x
Net Debt 2024 * 1.49B 970M Net Debt 2025 * 1.42B 925M EV / Sales 2025 * 1.29 x
P/E ratio 2024 *
-1.54 x
P/E ratio 2025 *
30.8 x
Employees -
Yield 2024 *
-
Yield 2025 *
1.72%
Free-Float 87.61%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Primary Health Care Limited

Managers TitleAgeSince
Chief Executive Officer - 23-02-28
Director of Finance/CFO - 20-01-31
Chief Tech/Sci/R&D Officer - 21-03-31
Members of the board TitleAgeSince
Director/Board Member 67 15-08-02
Chairman 65 21-02-24
Director/Board Member - 22-03-30
More insiders
Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Company’s brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.
Related indices
More about the company